Evidence mapPaperPMID 37252118Full record

ArticleFrontiers in cardiovascular medicine2023

The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction.

Raquel Costa Silva Dantas-Komatsu, Marina Sampaio Cruz, Paula Paccielli Freire, Rosiane Viana Zuza Diniz, Raul Hernandes Bortolin, Otávio Cabral-Marques, Kamilla Batista da Silva Souza, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata, Bruna Zavarize Reis and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Raquel Costa Silva Dantas-KomatsuPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Marina Sampaio CruzPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Paula Paccielli FreirePostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Rosiane Viana Zuza DinizDepartment of Clinical Medicine, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Raul Hernandes BortolinDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
Otávio Cabral-MarquesPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Kamilla Batista da Silva SouzaDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Mario Hiroyuki HirataDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
Rosario Dominguez Crespo HirataDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
Bruna Zavarize ReisDepartment of Nutrition, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Igor JurisicaDivision of Orthopedic Surgery, Schroeder Arthritis Institute and Data Science Discovery Centre for Chronic Diseases, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Vivian Nogueira SilbigerDepartment of Clinical and Toxicology Analysis, Federal University of Rio Grande do Norte, Natal, Brazil.
Andre Ducati LuchessiPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Universidade de São Paulo · BRUniversidade Federal do Rio Grande do Norte · BRUniversity Health Network · CAUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute ST-elevation myocardial infarction (STEMI) can lead to adverse cardiac remodeling, resulting in left ventricular systolic dysfunction (LVSd) and heart failure. Epigenetic regulators, such as microRNAs, may be involved in the physiopathology of LVSd. Objective: This study explored microRNAs in peripheral blood mononuclear cells (PBMC) of post-myocardial infarction patients with LVSd. Methods: Post-STEMI patients were grouped as having (LVSd, Results: The let-7b-5p (AUC: 0.807; 95% CI: 0.63-0.98; Conclusion: LVSd alters the expression of let-7b-5p, miR-326, and miR-125a-3p in PBMC from post-STEMI, indicating their potential involvement in the cardiac dysfunction physiopathology and highlighting these miRNAs as possible LVSd biomarkers.

Indexed as

enrichment analysisheart failureleft ventricular systolic dysfunctionmiRNAmyocardial infarctionPBMC

Identifiers

PMID37252118
PMCPMC10218134
OpenAlexW4378745970

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.